212790-31-3 Usage
Description
CP 481715, also known as 3-Cyano-4-(pyridin-4-yl)-6-(trifluoromethyl)pyridin-2-amine, is a synthetic chemical compound belonging to the group of pyridine derivatives. It is a potent and selective inhibitor of the enzyme JAK2 (Janus kinase 2), which plays a critical role in the development and progression of myeloproliferative neoplasms and other inflammatory diseases. CP 481715 has shown promising results in preclinical studies for the treatment of myelofibrosis, a chronic and progressive bone marrow disorder. Its mechanism of action involves the inhibition of JAK2-mediated signaling pathways, which are essential for the proliferation and survival of abnormal hematopoietic cells. CP 481715 has the potential to be developed as a targeted therapy for myelofibrosis and other JAK2-driven diseases, and further research is ongoing to evaluate its safety and efficacy in clinical trials.
Uses
Used in Pharmaceutical Industry:
CP 481715 is used as a targeted therapy for the treatment of myelofibrosis, a chronic and progressive bone marrow disorder. It works by inhibiting the JAK2 enzyme, which is involved in the development and progression of myeloproliferative neoplasms and other inflammatory diseases.
Used in Research Applications:
CP 481715 is used as a research tool to study the role of JAK2 in various diseases and to evaluate its potential as a therapeutic agent for the treatment of JAK2-driven conditions. It is also used to investigate the underlying mechanisms of JAK2-mediated signaling pathways and their contribution to the proliferation and survival of abnormal hematopoietic cells.
Check Digit Verification of cas no
The CAS Registry Mumber 212790-31-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,2,7,9 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 212790-31:
(8*2)+(7*1)+(6*2)+(5*7)+(4*9)+(3*0)+(2*3)+(1*1)=113
113 % 10 = 3
So 212790-31-3 is a valid CAS Registry Number.
212790-31-3Relevant articles and documents
Process development of CP-481715, a novel CCR1 antagonist
Li, Bryan,Andresen, Brian,Brown, Matthew F.,Buzon, Richard A.,Chiu, Charles K.-F.,Couturier, Michel,Dias, Eric,Urban, Frank J.,Jasys, V. John,Kath, John C.,Kissel, William,Le, Tung,Li, Z. Jane,Negri, Joanna,Poss, Christopher S.,Tucker, John,Whritenour, David,Zandi, Kathleen
, p. 466 - 471 (2012/12/25)
Process development for the synthesis of 2-quinoxalinecarboxamide, N-[(1S,2S,4R)-4-(aminocarbonyl)-1-[(3-fluorophenyl)-methyl]-2, 7-dihydroxy-7-methyloctyl] is described. An optimized and streamlined process starting from lactone 2 was developed: Lactone
Dihydoxyhexanoic acid derivatives, their intermediates, and methods of making
-
Page 16, (2010/02/05)
This invention relates to dihydroxyhexanoic acid derivatives and their intermediates, as well as to methods of preparing such compounds. Additionally, present invention relates to removing a protecting group from a protected amine wherein the method comprises reacting the protected amine with phosphoric acid.
